Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Arcus Biosciences
Arcus Biosciences
Gilead invests $320M in Arcus to increase stake to 33%
Medical Marketing and Media
Wed, 01/31/24 - 10:32 pm
Gilead Sciences
Arcus Biosciences
immuno-oncology
Gilead stops phase 3 TIGIT trial, doubling down on other studies and pumping $320M into partner Arcus
Fierce Biotech
Tue, 01/30/24 - 10:34 am
Gilead Sciences
Arcus Biosciences
Tigit
lung cancer
clinical trials
Gilead Sciences and Arcus Biosciences report cancer trial data
Clinical Trials Arena
Tue, 11/7/23 - 09:46 am
Gilead Sciences
Arcus Biosciences
domvanalimab
zimberelimab
upper GI cancers
clinical trials
Arcus and Gilead terminate development for etrumadenant in prostate cancer
Clinical Trials Arena
Tue, 08/8/23 - 10:36 pm
Arcus Biosciences
Gilead Sciences
prostate cancer
etrumadenant
ASCO: Gilead and Arcus's Cancer Immunotherapy Combo Faces Scrutiny Over Lower Survival Rates
BioSpace
Sun, 06/4/23 - 04:27 pm
ASCO 2023
Gilead Sciences
Arcus Biosciences
anti-TIGIT
non-small cell lung cancer
domvanalimab
Biotech heads towards big catalysts
EP Vantage
Tue, 03/28/23 - 10:24 am
biotech
clinical trials
Alnylam Pharmaceuticals
Arcus Biosciences
Argenx
Arrowhead Pharmaceuticals
Axsome Therapeutics
Bavarian Nordic
FibroGen
Gilead Sciences
Incyte
Morphic Therapeutic
PTC Therapeutics
Syndax Pharmaceuticals
Travere Therapeutics
Vaxcyte
Three TIGIT players look to surprise in 2023
EP Vantage
Fri, 01/13/23 - 10:06 am
anti-TIGIT
Roche
Merck
Gilead Sciences
Arcus Biosciences
Gilead, Arcus hope to ease TIGIT anxieties with latest trial data tease
Fierce Biotech
Mon, 11/28/22 - 07:37 pm
Gilead Sciences
Arcus Biosciences
clinical trials
domvanalimab
zimberelimab
non-small cell lung cancer
Opportunities arise for once-spurned partners
EP Vantage
Fri, 05/13/22 - 10:34 am
Pfizer
Biohaven
licensing
M&A
Aurinia
Bristol Myers Squibb
AbbVie
Alector
Arcus Biosciences
Biogen
Blueprint Medicines
CureVac
Gilead Sciences
GSK
Incyte
MorphoSys
Roche
Nestle
SAGE Therapeutics
Sarepta Therapeutics
Seres Therapeutics
Syndax
Why Arcus Biosciences Stock Is On Fire Today
Motley Fool
Thu, 11/18/21 - 10:41 am
Arcus Biosciences
Gilead Sciences
anti-TIGIT
etrumadenant
quemliclustat
Arcus declares cryptic interim win for closely watched anti-TIGIT drug, but you'll have to wait for the data
Endpoints
Wed, 06/23/21 - 10:32 pm
Arcus Biosciences
anti-TIGIT
Roche
8 key clinical trials to watch for the rest of 2021
BioPharma Dive
Mon, 06/21/21 - 11:11 am
clinical trials
Merck
Ridgeback Biotherapeutics
COVID-19
Intellia Therapeutics
transthyretin amyloidosis
Arcus Biosciences
Gilead Sciences
lung cancer
Sanofi
GSK
vaccines
uniQure
Huntington's disease
Mirati Therapeutics
gene editing
Seres Therapeutics
ulcerative colitis
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Arcus nears crunch time for Gilead opt-in
EP Vantage
Thu, 06/10/21 - 10:47 am
Arcus Biosciences
anti-TIGIT
clinical trials
Gilead Sciences
monoclonal antibodies
Gilead Is Said to Hold Arcus Stake Talks, Spurring 54% Rally
Bloomberg
Wed, 04/15/20 - 11:22 pm
Gilead Sciences
Arcus Biosciences
Alphabet
Roche move endorses Iteos’s Tigit widget
EP Vantage
Tue, 03/3/20 - 10:52 am
Roche
Tigit
tiragolumab
Arcus Biosciences
iTeos Therapeutics
Arcus and Roche Partner on Colorectal and Pancreatic Cancer Trials
BioSpace
Thu, 12/19/19 - 12:45 pm
Roche
Genentech
Arcus Biosciences
clinical trials
colorectal cancer
pancreatic cancer
AB928
Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories
CP Wire
Fri, 07/13/18 - 11:55 am
AB928
Arcus Biosciences
Taiho Pharmaceutical
oncology
Asia
Japan
Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories
Fri, 07/13/18 - 09:29 am
AB928
Arcus Biosciences
Taiho Pharmaceutical
Arcus Biosciences and Infinity Pharmaceuticals Partner to Evaluate Triple-Combination Therapy in Breast and Ovarian Cancer
CP Wire
Tue, 06/26/18 - 09:43 am
Arcus Biosciences
Infinity Pharmaceuticals
drug development
IPI-549
AB928
AB122
breast cancer
ovarian cancer
Arcus Biosciences and Infinity Pharmaceuticals Partner to Evaluate Triple-Combination Therapy in Breast and Ovarian Cancer
Tue, 06/26/18 - 09:23 am
Arcus Biosciences
Infinity Pharmaceuticals
breast cancer
ovarian cancer